Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers
暂无分享,去创建一个
C Caldas | N L Barbosa-Morais | S. Tavaré | S. Chin | C. Caldas | S. Aparicio | J. Brenton | A. Teschendorff | J. Robertson | Yanzhong Wang | N. Barbosa-Morais | N. Thorne | A. Naderi | S. Pinder | N. Iyer | Y. Wang | M. Vias | I. Roberts | M. García | T. Kranjac | I. Ellis | S Tavaré | J F R Robertson | I Roberts | S-F Chin | J D Brenton | I Ellis | M J Garcia | S E Pinder | S Aparicio | Y Wang | N P Thorne | A E Teschendorff | M Vias | A Naderi | N G Iyer | T Kranjac | María J. García | Carlos Caldas | Natalie P. Thorne | Andrew E. Teschendorff | Sarah E Pinder | Ali Naderi | Ian Roberts | N. G. Iyer | John F.R. Robertson | Samuel Aparicio | S. Tavaré | Ian O. Ellis
[1] J Piper,et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[2] Kylie L. Gorringe,et al. Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers : a new approach for the molecular analysis of paraffin-embedded cancer tissue. , 2001, The American journal of pathology.
[3] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[4] Jorge S. Reis-Filho,et al. Molecular Cytogenetic Identification of Subgroups of Grade III Invasive Ductal Breast Carcinomas with Different Clinical Outcomes , 2004, Clinical Cancer Research.
[5] Richard M. Simon,et al. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data , 2002, Bioinform..
[6] J. Andersen,et al. Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality. , 1999, Cancer genetics and cytogenetics.
[7] A. Hanby,et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. , 1999, Cancer research.
[8] Ajay N. Jain,et al. Breast tumor copy number aberration phenotypes and genomic instability , 2006, BMC Cancer.
[9] R. Fulthorpe,et al. Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. , 2004, Molecular endocrinology.
[10] J. Varley,et al. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma , 1997, Oncogene.
[11] Teri Oldaker,et al. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients , 1993, Breast Cancer Research and Treatment.
[12] P. V. van Diest,et al. Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry , 2004, British Journal of Cancer.
[13] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[14] T. Higashiyama,et al. Classification of Human Breast Cancer Using Gene Expression Profiling as a Component of the Survival Predictor Algorithm , 2004, Clinical Cancer Research.
[15] R. Marcos,et al. The Fanconi anaemia genome stability and tumour suppressor network. , 2002, Mutagenesis.
[16] Stefan Handt,et al. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization , 2001, The Journal of pathology.
[17] Carlos Caldas,et al. Identification and validation of prognostic markers in breast cancer with the complementary use of array‐CGH and tissue microarrays , 2005, The Journal of pathology.
[18] Barbara J. Trask,et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes , 2004, Cancer Research.
[19] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Nicolas Stransky,et al. Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas. , 2005, Cancer research.
[21] Mattias Höglund,et al. Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications , 2005, Oncogene.
[22] O. Kallioniemi,et al. Genome screening by comparative genomic hybridization. , 1997, Trends in genetics : TIG.
[23] T. Speed,et al. Statistical issues in cDNA microarray data analysis. , 2003, Methods in molecular biology.
[24] R Tibshirani,et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification , 2006, Oncogene.
[25] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[26] Joel Greshock,et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.
[27] A. Patchefsky,et al. Interobserver reproducibility of histopathological features in stage II breast cancer , 1985, Breast Cancer Research and Treatment.
[28] C. Caldas,et al. Absence of rearrangements in the BRCA2 gene in human cancers , 2001, British Journal of Cancer.
[29] J Isola,et al. Molecular cytogenetics of primary breast cancer by CGH , 1998, Genes, chromosomes & cancer.
[30] F. Rösel,et al. Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer. , 2002, Cancer letters.
[31] Maria Teresa Landi,et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. , 2005, Journal of the National Cancer Institute.
[32] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] Peter Schraml,et al. Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer , 2004, Cancer Research.
[34] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[35] T. Visakorpi,et al. Mapping the amplification of EIF3S3 in breast and prostate cancer , 2000, Genes, chromosomes & cancer.
[36] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[37] I. Ellis,et al. Pathological prognostic factors in breast cancer. , 1999, Critical reviews in oncology/hematology.
[38] J. Zavadil,et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. , 2004, The EMBO journal.
[39] P. Lichter,et al. Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue. , 2005, Cancer research.
[40] Roland Eils,et al. High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer , 2006, Clinical Cancer Research.
[41] S. Saydam,et al. DNA copy number changes detected by comparative genomic hybridization and their association with clinicopathologic parameters in breast tumors. , 2003, Cancer genetics and cytogenetics.
[42] Joe W. Gray,et al. Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas , 2001, Nature Genetics.
[43] J. Zavadil,et al. Integration of TGF‐β/Smad and Jagged1/Notch signalling in epithelial‐to‐mesenchymal transition , 2004 .
[44] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] Jorma Isola,et al. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.
[46] J. Russo,et al. Evidence for the notch signaling pathway on the role of estrogen in angiogenesis. , 2004, Molecular endocrinology.